- Corporate Officers - K
- Kearney Terrence C
Insider Trading History of Kearney Terrence C
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Kearney Terrence C since 2006.
This trader's CIK number is 1289098.
At the time of last reporting, Kearney Terrence C was the Director of Vertex Pharmaceuticals Inc / Ma. (stock ticker symbol VRTX).
Also see all insider trading activities at Vertex Pharmaceuticals Inc / Ma.
Note that in the past
Kearney Terrence C also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Hospira Inc (HSP) by Kearney Terrence C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2010 | HSP | 0 | $0 | 300,640 | $17,198,568 | 421,011 | $16,707,070 |
| 2009 | HSP | 0 | $0 | 2,281 | $104,926 | 92,715 | $3,418,860 |
| 2007 | HSP | 0 | $0 | 10,033 | $429,512 | 132,835 | $4,029,997 |
| 2006 | HSP | 0 | $0 | 0 | $0 | 3,898 | $89,236 |
Yearly summary of insider trading at Vertex Pharmaceuticals Inc / Ma (VRTX) by Kearney Terrence C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | VRTX | 0 | $0 | 10,000 | $3,500,000 | 10,000 | $1,275,400 |
| 2015 | VRTX | 0 | $0 | 68,125 | $8,898,555 | 69,625 | $3,954,780 |
Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by Kearney Terrence C
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | XLRN | 0 | $0 | 37,500 | $4,474,500 | 37,500 | $1,081,387 |
Insider trading activities at 3 companies by Kearney Terrence C:
1. Hospira Inc (HSP)
2. Vertex Pharmaceuticals Inc / Ma (VRTX)
3. Acceleron Pharma Inc (XLRN)
Table 1. Insider trading of Hospira Inc (HSP) by Kearney Terrence C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2010-12-16 | HSP | Sale | 74,643 | 57.00 | 4,254,651 |
| 2010-12-15 | HSP | Sale | 105,357 | 57.03 | 6,008,825 |
| 2010-12-15 | HSP | Option Ex | 70,000 | 32.47 | 2,272,900 |
| 2010-10-21 | HSP | Option Ex | 83,384 | 52.87 | 4,408,762 |
| 2010-10-21 | HSP | Sale | 29,306 | 59.00 | 1,729,054 |
| 2010-09-27 | HSP | Option Ex | 136,097 | 33.49 | 4,557,480 |
| 2010-09-27 | HSP | Sale | 91,334 | 57.00 | 5,206,038 |
| 2010-09-21 | HSP | Option Ex | 10,004 | 44.87 | 448,879 |
| 2010-09-16 | HSP | Option Ex | 6,781 | 43.93 | 297,889 |
| 2010-04-20 | HSP | Option Ex | 94,954 | 41.55 | 3,944,958 |
| 2010-03-30 | HSP | Option Ex | 15,212 | 39.22 | 596,614 |
| 2010-02-19 | HSP | Option Ex | 4,579 | 39.22 | 179,588 |
| 2009-11-05 | HSP | Option Ex | 2,281 | 43.80 | 99,907 |
| 2009-11-05 | HSP | Sale | 2,281 | 46.00 | 104,926 |
| 2009-10-19 | HSP | Option Ex | 79,028 | 36.84 | 2,911,075 |
| 2009-09-29 | HSP | Option Ex | 11,406 | 35.76 | 407,878 |
| 2007-12-10 | HSP | Option Ex | 7,722 | 35.09 | 270,995 |
| 2007-11-29 | HSP | Option Ex | 3,116 | 34.22 | 106,629 |
| 2007-11-28 | HSP | Option Ex | 30,530 | 29.71 | 907,046 |
| 2007-11-28 | HSP | Sale | 10,033 | 42.81 | 429,512 |
| 2007-03-02 | HSP | Option Ex | 38,768 | 31.31 | 1,213,787 |
| 2007-01-29 | HSP | Option Ex | 19,914 | 29.32 | 583,858 |
| 2007-01-29 | HSP | Option Ex | 19,914 | 29.32 | 583,858 |
| 2007-01-23 | HSP | Option Ex | 12,871 | 28.27 | 363,824 |
| 2006-12-18 | HSP | Option Ex | 3,898 | 22.89 | 89,236 |
Table 2. Insider trading of Vertex Pharmaceuticals Inc / Ma (VRTX) by Kearney Terrence C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-08-10 | VRTX | Option Ex | 10,000 | 127.54 | 1,275,400 |
| 2023-08-10 | VRTX | Sale | 10,000 | 350.00 | 3,500,000 |
| 2015-05-19 | VRTX | Option Ex | 1,500 | 56.99 | 85,485 |
| 2015-04-27 | VRTX | Option Ex | 68,125 | 56.80 | 3,869,295 |
| 2015-04-27 | VRTX | Sale | 68,125 | 130.62 | 8,898,555 |
Table 3. Insider trading of Acceleron Pharma Inc (XLRN) by Kearney Terrence C
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-10-12 | XLRN | Sale | 37,500 | 119.32 | 4,474,500 |
| 2020-10-12 | XLRN | Option Ex | 37,500 | 28.84 | 1,081,387 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kearney Terrence C
(Director of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.